Related references
Note: Only part of the references are listed.Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product
Trudy Straetemans et al.
MOLECULAR THERAPY (2020)
Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells
Inez Johanna et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Identification of a tumor-specific allo-HLA-restricted γδTCR
G. J. J. Kierkels et al.
BLOOD ADVANCES (2019)
GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
Trudy Straetemans et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
Maaike V. J. Braham et al.
ONCOIMMUNOLOGY (2018)
Flow cytometry in cell-based pharmacokinetics or cellular kinetics in adoptive cell therapy
Vellalore N. Kakkanaiah et al.
BIOANALYSIS (2018)
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Sonia Guedan et al.
JCI INSIGHT (2018)
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia
Karen Thudium Mueller et al.
BLOOD (2017)
Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice
Yuho Najima et al.
BLOOD (2016)
The next step toward GMP-grade production of engineered immune cells
Guido J. J. Kierkels et al.
ONCOIMMUNOLOGY (2016)
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
Saida Dadi et al.
CELL (2016)
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen et al.
CELL REPORTS (2016)
Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer
Trudy Straetemans et al.
CLINICAL CANCER RESEARCH (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Yang Xu et al.
BLOOD (2014)
Hunting for clinical translation with innate-like immune cells and their receptors
W. Scheper et al.
LEUKEMIA (2014)
Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?
Gabrielle M. Siegers et al.
MOLECULAR THERAPY (2014)
Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis
G. Roda et al.
MUCOSAL IMMUNOLOGY (2014)
Cancer immunotherapy using γδT cells: dealing with diversity
Wouter Scheper et al.
FRONTIERS IN IMMUNOLOGY (2014)
Clinical applications of gamma delta T cells with multivalent immunity
Drew C. Deniger et al.
FRONTIERS IN IMMUNOLOGY (2014)
Anti-metastatic potential of human Vδ1+ γδ T cells in an orthotopic mouse xenograft model of colon carcinoma
Christel Devaud et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells
Adrienne M. Luoma et al.
IMMUNITY (2013)
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
W. Scheper et al.
LEUKEMIA (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs
Cordula Gruender et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Victoria Marcu-Malina et al.
BLOOD (2011)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell-based Immunotherapy
Karin Schilbach et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Expansion of Vδ1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins
Silvia Catellani et al.
BLOOD (2007)
Perspectives of gamma delta T cells in tumor immunology
Dieter Kabelitz et al.
CANCER RESEARCH (2007)
Vδ1 T cell receptor binds specifically to MHC I chain related A:: Molecular and biochemical evidences
JP Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection
EC Morris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid
A Poggi et al.
CANCER RESEARCH (2004)
HLA-G modulates immune responses by diverse receptor interactions
V Hofmeister et al.
SEMINARS IN CANCER BIOLOGY (2003)